Stay updated on Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial
Sign up to get notified when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.

Latest updates to the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5.SummaryDifference0.1%

- Check11 days agoChange DetectedNo additions or deletions are recorded for this page; the study details content remains unchanged. No text changes were captured in the provided data.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing v3.5.3. This reflects a minor template update and does not modify the study information presented on the page.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page revision marker was updated from v3.5.2 to v3.5.3, reflecting a site/version update without changing the study information presented.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check68 days agoChange DetectedAdded a related topic term, Severe myoclonic epilepsy in infancy, to the page's topics section.SummaryDifference0.2%

Stay in the know with updates to Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.